Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricardo Alonso

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
Multiple Sclerosis and Related Disorders|October 18, 2025
Comparative analysis of AQP4-IgG-positive and AQP4-IgG-negative NMOSD: A multicenter study in Latin AmericaRicardo Alonso, Carlos Navas, María Eugenia Balbuena, et al.
Multiple Sclerosis and Related Disorders|January 17, 2021
What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM)Edgar Carnero Contentti, Pablo A Lopez, Juan Pablo Pettinicchi, et al.
Multiple Sclerosis and Related Disorders|August 2, 2022
Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-βSteve Simpson-Yap, Ashkan Pirmani, Edward De Brouwer, et al.
Multiple Sclerosis and Related Disorders|May 23, 2020
Consensus recommendations for family planning and pregnancy in multiple sclerosis in argentinaNora Fernández Liguori, Ricardo Alonso, Amelia Alves Pinheiro, et al.
Journal of the Neurological Sciences|February 17, 2018
Corrigendum to "Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patients" [J. Neurol. Sci. 385C (2018) 217-224]Edgardo Cristiano, Ricardo Alonso, Amelia Alvez Pinheiro, et al.
Journal of the Neurological Sciences|February 7, 2018
Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patientsEdgardo Cristiano, Ricardo Alonso, Amelia Alvez Pinheiro, et al.
Neurological Research|October 2, 2022
Disease activity after discontinuation of disease-modifying therapies in patients with multiple sclerosis in Argentina: data from the nationwide registry RelevarEMZanga Gisela, Portinari Carla, Barber Josefina, et al.
Journal of the Neurological Sciences|May 26, 2024
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registryMaria A Piedrabuena, Jorge Correale, Marcela Fiol, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 15, 2020
COVID-19 in people with multiple sclerosis: A global data sharing initiativeLiesbet M Peeters, Tina Parciak, Clare Walton, et al.
Annals of Clinical and Translational Neurology|August 5, 2024
Application of the international criteria for optic neuritis in the Acute Optic Neuritis NetworkPhilipp Klyscz, Susanna Asseyer, Ricardo Alonso, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
Multiple Sclerosis and Related Disorders|October 18, 2025
Comparative analysis of AQP4-IgG-positive and AQP4-IgG-negative NMOSD: A multicenter study in Latin AmericaRicardo Alonso, Carlos Navas, María Eugenia Balbuena, et al.
Multiple Sclerosis and Related Disorders|January 17, 2021
What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM)Edgar Carnero Contentti, Pablo A Lopez, Juan Pablo Pettinicchi, et al.
Multiple Sclerosis and Related Disorders|August 2, 2022
Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-βSteve Simpson-Yap, Ashkan Pirmani, Edward De Brouwer, et al.
Multiple Sclerosis and Related Disorders|May 23, 2020
Consensus recommendations for family planning and pregnancy in multiple sclerosis in argentinaNora Fernández Liguori, Ricardo Alonso, Amelia Alves Pinheiro, et al.
Journal of the Neurological Sciences|February 17, 2018
Corrigendum to "Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patients" [J. Neurol. Sci. 385C (2018) 217-224]Edgardo Cristiano, Ricardo Alonso, Amelia Alvez Pinheiro, et al.
Journal of the Neurological Sciences|February 7, 2018
Argentinean recommendations on the identification of treatment failure in relapsing remitting multiple sclerosis patientsEdgardo Cristiano, Ricardo Alonso, Amelia Alvez Pinheiro, et al.
Neurological Research|October 2, 2022
Disease activity after discontinuation of disease-modifying therapies in patients with multiple sclerosis in Argentina: data from the nationwide registry RelevarEMZanga Gisela, Portinari Carla, Barber Josefina, et al.
Journal of the Neurological Sciences|May 26, 2024
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registryMaria A Piedrabuena, Jorge Correale, Marcela Fiol, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 15, 2020
COVID-19 in people with multiple sclerosis: A global data sharing initiativeLiesbet M Peeters, Tina Parciak, Clare Walton, et al.
Annals of Clinical and Translational Neurology|August 5, 2024
Application of the international criteria for optic neuritis in the Acute Optic Neuritis NetworkPhilipp Klyscz, Susanna Asseyer, Ricardo Alonso, et al.
Pageof 16